Pro Medicus Limited (ASX:PME)
Australia · Delayed Price · Currency is AUD 210.21
-5.71 (-2.64%)
At close: Jan 9, 2026
Pro Medicus Market Cap
Pro Medicus has a market cap or net worth of 22.56 billion as of January 8, 2026. Its market cap has decreased by -13.72% in one year.
Market Cap
22.56B
Enterprise Value
22.35B
Revenue
212.98M
Ranking
n/a
PE Ratio
196.11
Stock Price
210.21
Market Cap Chart
Since October 10, 2000, Pro Medicus's market cap has increased from 142.00M to 22.56B, an increase of 15,785.32%. That is a compound annual growth rate of 22.21%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 8, 2026 | 22.56B | -2.24% |
| Dec 31, 2025 | 23.07B | -11.72% |
| Dec 31, 2024 | 26.14B | 161.11% |
| Dec 29, 2023 | 10.01B | 73.45% |
| Dec 30, 2022 | 5.77B | -11.46% |
| Dec 31, 2021 | 6.52B | 83.09% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 81.96B |
| Cochlear | 17.17B |
| Sonic Healthcare | 10.94B |
| Ramsay Health Care | 8.03B |
| Ansell | 5.07B |
| Telix Pharmaceuticals | 3.73B |
| Mesoblast | 3.50B |
| 4DMedical | 2.46B |